VPAC2 Polyclonal Antibody | Invitrogen PA5-27162 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Invitrogen

other brands :

NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

product type :

antibody

product name :

VPAC2 Polyclonal Antibody

catalog :

PA5-27162

quantity :

100 µL

price :

US 474

clonality :

polyclonal

host :

domestic rabbit

conjugate :

nonconjugated

reactivity :

human

application :

western blot

product information

Product Type :

Antibody

Product Name :

VPAC2 Polyclonal Antibody

Catalog # :

PA5-27162

Quantity :

100 µL

Price :

US 474

Clonality :

Polyclonal

Purity :

Antigen affinity chromatography

Host :

Rabbit

Reactivity :

Human

Applications :

Western Blot: 1:500-1:3,000

Species :

Human

Isotype :

IgG

Storage :

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Description :

The Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2) is a member of a family of three G-protein coupled receptors which mediate VIP (vasoactive intestinal peptide) and PACAP (pituitary adenlyate cyclase activating peptide) function in a variety of tissues. Together, the VPAC1 and VPAC2 receptors compose a subtype of the VIP receptor. Expression of the VIP and PACAP receptors has been linked to the presence of human tumors.

Immunogen :

Synthetic peptide corresponding to a region within amino acids 344 and 435 of Human VPAC2

Format :

Liquid

Applications w/Dilutions :

Western Blot: 1:500-1:3,000

Aliases :

C16DUPq36.3; DUP7q36.3; helodermin-preferring VIP receptor; PACAP type III receptor; Pacap type-3; PACAP3; PACAP-R3; PACAP-R-3; PACAPR-3; pituitary adenylate cyclase-activating polypeptide type III receptor; Pvr3; SCZD16; tcag7.970; vasoactive intestinal peptide receptor 2; vasoactive intestinal polypeptide receptor 2; vasopressive intestinal peptide receptor 2; VIP and PACAP receptor 2; VIP receptor subtype 2; Vip type-2 receptor; Vip2; Vip2 receptor; VIP2R; Vipr2; Vip-r2; VIP-R-2; VPAC2; VPAC2 receptor; VPAC2R; VPCAP2R